Sotera Health director granted 14,970 RSUs
Krause Kenneth D. reported acquisition or exercise transactions in this Form 4 filing.
Rhea-AI Filing Summary
Krause Kenneth D. reported acquisition or exercise transactions in this Form 4 filing.
Sotera Health Co director Kenneth D. Krause received a grant of 14,970 restricted stock units (RSUs) on May 22, 2026 as equity compensation. Each RSU represents the right to receive one share of common stock, subject to vesting conditions. The RSUs vest in full on the earlier of the first anniversary of the grant date or immediately before Sotera Health’s next regular annual shareholders meeting, as long as Krause continues serving as a non-employee director. The Form 4 shows this as a non-cash award, with 14,970 shares reported as directly owned following the transaction.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 14,970 shares
Grant/Award
1 txn
Insider
Krause Kenneth D.
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock, $0.01 par value per share ("Common Stock") | 14,970 | $0.00 | $0.00 |
Holdings After Transaction:
Common Stock, $0.01 par value per share ("Common Stock") — 14,970 shares (Direct)
Footnotes (1)
- F1. These securities consist of 14,970 restricted stock units ("RSUs") that were granted on May 22, 2026, pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incenctive Plan. Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. The RSUs will vest in full on the earlier of (i) the first anniversary of the date of grant, or (ii) the date immediately prior to the Issuer's next regular annual shareholders meeting, subject to the Reporting Person's continued service as a non-employee director of the Issuer through such date.
Key Figures
RSU grant size: 14,970 RSUs
Shares following transaction: 14,970 shares
Transaction price per share: $0.0000 per share
+2 more
5 metrics
RSU grant size
14,970 RSUs
Granted on May 22, 2026 to director Kenneth D. Krause
Shares following transaction
14,970 shares
Direct ownership reported after RSU award
Transaction price per share
$0.0000 per share
Indicates non-cash grant/award acquisition
Form type
Form 4
Insider acquisition via grant/award
Plan name
2020 Omnibus Incentive Plan
Governs the RSU grant terms
Key Terms
restricted stock units, RSUs, 2020 Omnibus Incenctive Plan, vesting conditions, +1 more
5 terms
restricted stock units financial
"These securities consist of 14,970 restricted stock units ("RSUs") that were granted on May 22, 2026"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
RSUs financial
"Each RSU represents the Reporting Person's right to receive one share of Common Stock"
RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.
2020 Omnibus Incenctive Plan financial
"pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incenctive Plan"
vesting conditions financial
"Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions"
Vesting conditions are the rules that determine when someone earning company stock or stock options actually gains the right to keep or sell them, typically based on staying with the company for a set time or meeting performance targets. Think of it like keys that unlock gradually — some unlock by calendar date, others only after agreed milestones. Investors care because vesting shapes management incentives, the timing of share sales, and the number of shares that can enter the market, which can affect a company's valuation and ownership mix.
non-employee director financial
"subject to the Reporting Person's continued service as a non-employee director of the Issuer through such date"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Sotera Health (SHC) report for Kenneth D. Krause?
Sotera Health reported that director Kenneth D. Krause received a grant of 14,970 restricted stock units. These RSUs were awarded as equity compensation and will convert into shares of common stock if the vesting conditions tied to his continued board service are met.
When do Kenneth D. Krause’s Sotera Health (SHC) RSUs vest?
The RSUs vest in full on the earlier of the first anniversary of the May 22, 2026 grant date or immediately before Sotera Health’s next regular annual shareholders meeting. Vesting requires Krause’s continued service as a non-employee director through the applicable vesting date.
What plan governs Kenneth D. Krause’s RSU award at Sotera Health (SHC)?
The RSU award was granted under the Sotera Health Company 2020 Omnibus Incentive Plan. This plan provides equity-based compensation, such as restricted stock units, to directors and other participants, aligning their interests with shareholders through share-based incentives instead of pure cash compensation.
Is Kenneth D. Krause’s Form 4 transaction in Sotera Health (SHC) an open-market purchase?
No, the Form 4 reports a grant-type acquisition coded as an award, not an open-market purchase. Krause paid no purchase price for the 14,970 RSUs; they were issued as compensation and will settle into shares only if the vesting requirements are satisfied.
AI-generated analysis. How Rhea-AI works. Not financial advice.
